Symptom control and health‐related quality of life in allergic rhinitis with and without comorbid asthma: A multicentre European study
Sign Up to like & getrecommendations! Published in 2023 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12209
Abstract: Abstract Background Allergic rhinitis (AR) is a major non‐communicable disease that affects the health‐related quality of life (HRQoL) of patients. However, data on HRQoL and symptom control in AR patients with comorbid asthma (AR +… read more here.
Keywords: symptom control; control; asthma; comorbid asthma ... See more keywords
How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Neurology"
DOI: 10.1007/s00415-019-09527-2
Abstract: Patients with cervical dystonia (CD) typically require regular injections of botulinum toxin to maintain symptomatic control. We aimed to document long-term patient satisfaction with CD symptom control in a large cohort of patients treated in… read more here.
Keywords: satisfaction; satisfaction symptom; symptom control; control ... See more keywords
Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2)
Sign Up to like & getrecommendations! Published in 2020 at "Trials"
DOI: 10.1186/s13063-020-04335-w
Abstract: Background The prevalence of inadequate symptom control among cancer patients is quite high despite the availability of definitive care guidelines and accurate and efficient assessment tools. Methods We will conduct a hybrid type 2 stepped… read more here.
Keywords: intervention; trial; symptom control; implementation ... See more keywords
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema.
Sign Up to like & getrecommendations! Published in 2022 at "Allergy and asthma proceedings"
DOI: 10.2500/aap.2022.43.220016
Abstract: Background: Hereditary angioedema (HAE) due to C1-inhibitor (C1-INH) deficiency is a rare genetic disorder characterized by disabling episodes of edema that commonly affect the skin as well as the gastrointestinal tract and upper airway. Prophylactic… read more here.
Keywords: subcutaneous inhibitor; hereditary angioedema; symptom control; prophylactic therapy ... See more keywords